Dexamethasone

Generic Name
Dexamethasone
Brand Names
Baycadron, Ciprodex, Decadron, Dexamethasone Intensol, Dextenza, Dioptrol, Hexadrol, Hidex 6-day Taper, Maxidex, Maxitrol, Neofordex, Ozurdex, Taperdex 12 Day Taper, Taperdex 6 Day Taper, Taperdex 7-day Taper, Tobradex, Zcort 7 Day Taper
Drug Type
Small Molecule
Chemical Formula
C22H29FO5
CAS Number
50-02-2
Unique Ingredient Identifier
7S5I7G3JQL
Background

Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.

Dexamethasone was granted FDA approval on 30 October 1958. In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.

Indication

Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Oral tablets are indicated for the treatment of multiple myeloma. An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye. Various ophthalmic formulations are indicated for inflammatory conditions of the eye.

Associated Conditions
Acute Gouty Arthritis, Acute Leukemia, Acute Otitis Externa, Acute Otitis Media (AOM), Adrenocortical Hyperfunction, Adrenocortical Insufficiency, Allergic Conjunctivitis (AC), Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aspiration Pneumonitis, Asthma, Atopic Dermatitis, Berylliosis, Bullous dermatitis herpetiformis, Bursitis, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Conjunctivitis, Contact Dermatitis, Cushing's Syndrome, Dermatitis, Diabetic Macular Edema (DME), Discoid Lupus Erythematosus (DLE), Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Episcleritis, Erythroblastopenia, Eye Infections, Eye allergy, Glaucoma, Hypercalcemia, Immune Thrombocytopenia (ITP), Infection, Inflammation, Inflammation of the External Auditory Canal, Intraocular Inflammation, Iridocyclitis, Iritis, Keloids Scars, Keratitis, Lichen Planus (LP), Lichen simplex chronicus, Loeffler's syndrome, Lymphoma, Macular Edema, Meningitis caused by Mycobacterium Tuberculosis, Middle ear inflammation, Mucosal Inflammation of the eye, Multiple Myeloma (MM), Muscle Inflammation caused by Cataract Surgery of the eye, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Non-infectious Posterior Uveitis, Ocular Infections, Irritations and Inflammations, Ocular Inflammation, Ocular Inflammation and Pain, Ocular Irritation, Ocular Itching, Ophthalmia, Sympathetic, Optic Neuritis, Otitis Externa, Pemphigus, Perennial Allergic Rhinitis (PAR), Phlyctenular keratoconjunctivitis, Postoperative Infections of the eyes caused by susceptible bacteria, Posttraumatic Osteoarthritis, Regional Enteritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Sarcoidosis, Scleritis, Seasonal Allergic Rhinitis, Secondary thrombocytopenia, Serum Sickness, Severe Seborrheic Dermatitis, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Tenosynovitis, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Uveitis, Vernal Keratoconjunctivitis, Acquired immune hemolytic anemia, Acute rheumatic carditis, Anterior eye segment inflammation, Corticosteroid-responsive dermatoses, Ear infection-not otherwise specified caused by susceptible bacteria, Exfoliative erythroderma, Granuloma annulare lesions, Non-suppurative Thyroiditis, Ocular bacterial infections, Severe Psoriasis, Steroid-responsive inflammation of the eye, Swelling of the eyes, Varicella-zoster virus acute retinal necrosis, Watery itchy eyes
Associated Therapies
-

Single Dose Versus Multiple Doses of Dexamethasone in Children With Acute Bronchiolitis

Phase 3
Completed
Conditions
First Posted Date
2005-09-21
Last Posted Date
2014-05-13
Lead Sponsor
The Hospital for Sick Children
Target Recruit Count
120
Registration Number
NCT00213226
Locations
🇨🇦

The Hospital for Sick Children, Toronto, Ontario, Canada

Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt

First Posted Date
2005-09-20
Last Posted Date
2022-08-18
Lead Sponsor
Goethe University
Target Recruit Count
20
Registration Number
NCT00199108
Locations
🇩🇪

University Hospital, Medical Dept. II, Frankfurt, Germany

Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors

Phase 1
Completed
Conditions
First Posted Date
2005-09-20
Last Posted Date
2017-12-06
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
27
Registration Number
NCT00201812
Locations
🇺🇸

Ohio State University Medical Center, Columbus, Ohio, United States

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

First Posted Date
2005-09-20
Last Posted Date
2007-10-19
Lead Sponsor
Johann Wolfgang Goethe University Hospital
Registration Number
NCT00199186
Locations
🇩🇪

Medizinische Klinik II, Johann Wolfgang Goethe Universität, Frankfurt/Main, Germany

Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

Phase 4
Completed
Conditions
First Posted Date
2005-09-20
Last Posted Date
2023-03-20
Lead Sponsor
Goethe University
Target Recruit Count
40
Registration Number
NCT00199095
Locations
🇩🇪

University Hospital, Medical Dept. II, Frankfurt, Germany

Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma

Phase 2
Completed
Conditions
First Posted Date
2005-09-20
Last Posted Date
2015-06-10
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
12
Registration Number
NCT00201695
Locations
🇺🇸

Ohio State University, Columbus, Ohio, United States

SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy).

First Posted Date
2005-09-19
Last Posted Date
2007-05-10
Lead Sponsor
Trans Tasman Radiation Oncology Group
Target Recruit Count
20
Registration Number
NCT00193869
Locations
🇦🇺

St George Hospital, Kogarah, New South Wales, Australia

Dexamethasone for Palliation - Brain Metastases

Phase 2
Completed
Conditions
First Posted Date
2005-09-16
Last Posted Date
2019-11-27
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
50
Registration Number
NCT00188864
Locations
🇨🇦

Princess Margaret Hospital, Toronto, Ontario, Canada

Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant

First Posted Date
2005-09-16
Last Posted Date
2017-06-26
Lead Sponsor
Fred Hutchinson Cancer Center
Target Recruit Count
30
Registration Number
NCT00182663
Locations
🇺🇸

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2024. All Rights Reserved by MedPath